EV/EBITDA
-34.56
+0.02+0.06%
33 min ago
Summary
- As of February 7, 2025, MNPR EV/EBITDA is -34.56, with a rise of +0.02 (+0.06%) during the most recent trading day.
- Over the past year, MNPR EV/EBITDA has dropped by -34.86 (-11620.00%).
- MNPR EV/EBITDA is now -11620.00% below its all-time high of 0.30.
Performance
MNPR EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
MNPR EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +0.1% | -0.1% | -0.1% |
| 1 m1 month | -90.1% | +90.1% | +86.0% |
| 3 m3 months | -205.8% | +205.8% | +191.2% |
| 6 m6 months | -6183.6% | +5814.9% | +1519.7% |
| ytdytd | -119.7% | +119.7% | +113.5% |
| 1 y1 year | -10000.0% | +9242.3% | +2930.3% |
| 5 y5 years | +1.6% | +59.2% | -39.8% |
MNPR EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -104.0% | -35.97 | +3.9% | |
| 3 m | 3-month | -10.93 | -216.2% | -35.97 | +3.9% |
| 6 m | 6-month | -0.22 | <-9999.0% | -35.97 | +3.9% |
| 1 y | 1-year | 0.30 | <-9999.0% | -35.97 | +3.9% |
| 3 y | 3-year | 0.30 | <-9999.0% | -35.97 | +3.9% |
| 5 y | 5-year | 0.30 | <-9999.0% | -35.97 | +3.9% |
| alltime | all time | 0.30 | <-9999.0% | -68.78 | +49.8% |
Monopar Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -34.56(+119.7%) |
| 2024 | -15.73(-6392.0%) |
| 2023 | 0.25(-111.7%) |
| Date | Value |
|---|---|
| 2022 | -2.14(-3.2%) |
| 2021 | -2.21(-73.0%) |
| 2020 | -8.20(-78.2%) |
| 2019 | -37.59 |
FAQ
- What is Monopar Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Monopar Therapeutics?
- What is MNPR EV/EBITDA year-to-date change?
- What is Monopar Therapeutics EV/EBITDA year-on-year change?
What is Monopar Therapeutics EV/EBITDA?
The current EV/EBITDA of MNPR is -34.56
What is the all time high EV/EBITDA for Monopar Therapeutics?
Monopar Therapeutics all-time high EV/EBITDA is 0.30
What is MNPR EV/EBITDA year-to-date change?
Monopar Therapeutics EV/EBITDA has changed by -18.83 (-119.71%) since the beginning of the year
What is Monopar Therapeutics EV/EBITDA year-on-year change?
Over the past year, MNPR EV/EBITDA has changed by -34.86 (-11620.00%)